2018-09-15： Research and Development of Innovative New Advanced TCMP

News from China SXT: Dr. Jingzhen Deng, the Chief Executive Officer and Chief Scientific Officer of Jiangsu SXT Pharmaceutical Co., Ltd., was invited for giving a special talk about “Research and Development of Innovative New Advanced TCMP” on Sep 15, 2018 in a seminar held by China Educational Association of Pharmaceutical which received warm responses and wide acclaim from the experts who come from the Quality and Metabolism of Chinese Medicine Research Lab of Jiangsu Branch Institute of CACMS, Jiangsu Hospital of TCM, Beijing Increase Innovative Medicine Co., Ltd., Beijing Clinic Medicine Research Institution, Shanghai Institute of Materia Medica of Chinese Academy of Sciences and Center of National New Drug Evaluation.

• Last：China SXT Pharmaceuticals, Inc. Announces Effectiveness of Registration Statement on Form F-1 and Pricing the Initial Public Offering of its Ordinary Shares at $4.00 per Share
• Next：Nasdaq’s Head of Healthcare Listings Shares 2018 Predictions for Biotech IPOs